Translocations involving the chromosomal region t(11;14) (q13.3;q32.3) are considered to be characteristic for mantle cell lymphomas (MCL) but have also been identified in other lymphoproliferative disorders (LPDs), such as B-prolymphocytic leukemia, and, less frequently, in plasma cell myelomas, B-cell chronic lymphocytic leukemia (B-CLL), and in splenic lymphomas with villous lymphocytes (SLVL). The t(11;14) rearrangement often leads to overexpression of the CCND1 protein. Determination of translocations involving the chromosomal region 11q13.3 can also help to distinguish MCL from other chronic lymphoproliferative disorders. Since the course of MCL is aggressive, and its response to chemotherapy is poor, differential diagnosis is clinically important. Additionally, it was also shown that a renal oncocytoma (RO) specific breakpoint is located in band 11q13.3, involving the CCND1 locus. The histologic features of RO may overlap with those of chromophobe renal cell carcinoma (ChRCC).